Isolated Hepatic Perfusion with TNF-alpha and Melphalan in Pigs
Author Information
Author(s): IHM Borel Rinkes, MR de Vries, AM Jonker, TJG Swaak, CE Hack, PTGA Nooyen, T Wiggers, AMM Eggermont
Primary Institution: Rotterdam Cancer Institute/University Hospital Rotterdam
Hypothesis
Isolated hepatic perfusion with TNF-alpha and melphalan is feasible and safe for treating irresectable hepatic malignancies.
Conclusion
The study found that isolated hepatic perfusion with TNF-alpha and melphalan is technically feasible and results in minimal systemic drug exposure and mild, transient hepatotoxicity.
Supporting Evidence
- Stable perfusion was achieved in all animals with minimal systemic leakage of TNF-alpha.
- All but one pig tolerated the procedure well, and no significant systemic toxicity was observed.
- Mild transient hepatotoxicity was seen to a similar extent in all animals, including controls.
Takeaway
Doctors tested a new way to treat liver cancer in pigs using special drugs, and it worked well without causing too many side effects.
Methodology
Ten healthy pigs underwent isolated hepatic perfusion with TNF-alpha and melphalan, with various measurements taken to assess toxicity and drug levels.
Limitations
The study was conducted in pigs, and results may not directly translate to humans.
Participant Demographics
Ten healthy pigs weighing 25-33 kg.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website